Natural compounds are one source that can be used to obtain alternative treatments and even new medicines to overcome cancer. 12,13 The Eriocaulaceae family is known as a source that has activity against cancer. As part of this family, Eriocaulon sieboldianum and Eriocaulon australe are used as adjunctive therapy for cancer in China. Both can inhibit cell proliferation and induce apoptosis. 14,15 Another species called E. cinereum has also been used as a traditional medicine to treat cancer by people in the Bangka Belitung area. This species, widely found in America, Africa, Australia, and Asia, can grow in muddy locations, has membranaceous leaves, trimerous flowers, and staminate flowers with completely fused sepals, and has been reported to be weeds in rice fields. [16][17][18][19] Previous research showed that the purer the content of E. cinereum is, the better the toxicity on MCF-7 and T47D breast cancer cells. In a cytotoxic test on MCF-7, ethyl acetate extract, the extract with the best activity after purification by fractionation using ethyl acetate, showed better cytotoxicity with an IC50 value of 214.75 μg/mL. The active isolate that was successfully isolated from the fraction, which is a flavonoid isolate, has an IC50 of 7.28 μg/mL. [20][21][22] The same results were also found upon testing toxicity on T47D cells. The subfraction containing terpenoids had a lower IC50 compared to the dichloromethane fraction, with IC50 values of 84.8 and 131.921 μg/mL, respectively. 23,24 However, research using this species on HeLa cervical cancer cells has only been done at the fraction level, with the best IC50 being in the ethyl acetate fraction with an IC50 of 235.65 μg/mL. 25,26 Based on previous research, we hypothesized that the subfraction and isolates from this fraction would have better activity than the crude extract on HeLa